Prevention of the development of heart failure with preserved ejection fraction by the phosphodiesterase-5A inhibitor vardenafil in rats with type 2 diabetes. [electronic resource]
Producer: 20171109Description: 326-336 p. digitalISSN:- 1879-0844
- Animals
- Apoptosis -- drug effects
- Cardiomegaly -- prevention & control
- Cyclic GMP -- metabolism
- Diabetes Mellitus, Type 2 -- metabolism
- Echocardiography
- Fibrosis
- Heart -- drug effects
- Heart Failure -- diagnostic imaging
- Myocardium -- pathology
- Myocytes, Cardiac -- drug effects
- Oxidative Stress -- drug effects
- Phosphodiesterase 5 Inhibitors -- pharmacology
- Rats
- Rats, Zucker
- Stroke Volume
- Vardenafil Dihydrochloride -- pharmacology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.